Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice

Prior work has shown that parenterally administered anti-CD20 (5D2) inhibits CD4(+) T cell priming in response to challenge with Pneumocystis murina and predisposes to pneumonia. In this study, we investigated the effect of subcutaneous anti-CD20 antibody and Pneumocystis infection. In mice with pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Guixiang, Noell, Kristin, Weckbecker, Gisbert, Kolls, Jay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103991/
https://www.ncbi.nlm.nih.gov/pubmed/33952667
http://dx.doi.org/10.1128/mSphere.01144-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103991/
https://www.ncbi.nlm.nih.gov/pubmed/33952667
http://dx.doi.org/10.1128/mSphere.01144-20

Ejemplares similares